Revvity | Bienes



Assets Cambio Fecha
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Agilent USD 11.91B 68M 2025-01
Align Technology USD 6.1B 111.78M 2025-03
Bio Techne USD 2.64B 26.16M 2025-03
Bio-Rad Laboratories USD 9.53B 162.8M 2025-03
Bruker USD 5.93B 122.7M 2025-03
Celltrion KRW 20.96T 20.29T 2025-03
Charles River Laboratories USD 7.58B 54.02M 2025-03
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Danaher USD 79.12B 1.57B 2025-03
Dentsply International USD 6.05B 297M 2025-03
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Exact Sciences USD 5.71B 217.07M 2025-03
Hologic USD 8.55B 183.6M 2025-03
Illumina USD 6.18B 121M 2025-03
Intuitive Surgical USD 19.22B 477.2M 2025-03
IQVIA Holdings USD 27.32B 423M 2025-03
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Laboratory Of America USD 17.6B 775.2M 2025-03
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Mettler Toledo International USD 3.23B 5.32M 2025-03
Myriad Genetics USD 1.01B 21.5M 2025-03
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Pharma Mar EUR 333.5M 16.15M 2025-03
Qiagen NV USD 5.69B 580.57M 2024-12
Quest Diagnostics USD 15.8B 356M 2025-03
Quidel USD 6.46B 38M 2025-03
Repligen USD 2.85B 22.48M 2025-03
Revvity USD 12.36B 31.75M 2025-03
Sartorius EUR 10.11B 9.3M 2025-03
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Thermo Fisher Scientific USD 99.04B 1.72B 2025-03
Tilray USD 4.19B 70.11M 2024-11
Waters USD 4.59B 37.78M 2025-03
Zz Pientze Pharmaceu 18.48B 944.93M 2025-03



Revvity Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.